HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Placido Bramanti Selected Research

alpha-cyclodextrin

7/2017Moringa isothiocyanate complexed with α-cyclodextrin: a new perspective in neuroblastoma treatment.
6/2017The α-cyclodextrin complex of the Moringa isothiocyanate suppresses lipopolysaccharide-induced inflammation in RAW 264.7 macrophage cells through Akt and p38 inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Placido Bramanti Research Topics

Disease

61Inflammation (Inflammations)
10/2021 - 02/2005
50Spinal Cord Injuries (Spinal Cord Injury)
01/2020 - 02/2005
41Multiple Sclerosis
12/2022 - 11/2005
26Myelitis
04/2012 - 02/2005
22Neurodegenerative Diseases (Neurodegenerative Disease)
06/2021 - 01/2014
20Wounds and Injuries (Trauma)
03/2020 - 02/2005
19Parkinson Disease (Parkinson's Disease)
08/2021 - 04/2006
16Stroke (Strokes)
09/2022 - 02/2005
16Neoplasms (Cancer)
01/2021 - 01/2009
14Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
09/2019 - 12/2009
13Alzheimer Disease (Alzheimer's Disease)
06/2021 - 12/2010
13Consciousness Disorders
02/2021 - 11/2013
13Edema (Dropsy)
07/2020 - 02/2005
12Cognitive Dysfunction
12/2022 - 08/2012
11Neuroinflammatory Diseases
10/2021 - 01/2014
10Dementia (Dementias)
09/2019 - 12/2010
9Pain (Aches)
02/2022 - 07/2008
9Brain Injuries (Brain Injury)
02/2021 - 02/2011
9Reperfusion Injury
11/2015 - 05/2007
9Ischemia
12/2014 - 04/2007
8Infections
09/2020 - 01/2010
8Relapsing-Remitting Multiple Sclerosis
07/2020 - 11/2004
7Neuroblastoma
09/2020 - 11/2010
7Demyelinating Diseases (Demyelinating Disease)
07/2020 - 04/2011
7Epilepsy (Aura)
04/2019 - 06/2009
7Seizures (Absence Seizure)
10/2016 - 06/2009
7Erectile Dysfunction
01/2016 - 03/2009
7Schizophrenia (Dementia Praecox)
02/2015 - 02/2010
7Shock
07/2011 - 10/2008
6Mood Disorders (Mood Disorder)
02/2022 - 06/2010
6Persistent Vegetative State (Vegetative State)
08/2021 - 01/2015
6Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2021 - 01/2015
6Traumatic Brain Injuries (Traumatic Brain Injury)
03/2020 - 04/2011
6Neuralgia (Stump Neuralgia)
11/2017 - 05/2010
6Pleurisy (Pleuritis)
10/2011 - 04/2009
6Multiple Organ Failure (MODS)
07/2011 - 02/2008
5Chronic Pain
02/2022 - 01/2020
5COVID-19
12/2021 - 07/2020
5Migraine Disorders (Migraine)
07/2019 - 01/2005
5Body Weight (Weight, Body)
07/2011 - 01/2009
4Fibrosis (Cirrhosis)
09/2020 - 04/2011
4Hypoxia (Hypoxemia)
05/2020 - 04/2007
4Amyloid Plaque
01/2020 - 12/2016
4Glioblastoma (Glioblastoma Multiforme)
09/2018 - 04/2016
4Dyskinesias (Dyskinesia)
09/2018 - 12/2011

Drug/Important Bio-Agent (IBA)

313-nitrotyrosineIBA
10/2015 - 04/2005
29CytokinesIBA
03/2020 - 11/2005
20Peroxidase (Myeloperoxidase)IBA
04/2011 - 02/2005
19Pharmaceutical PreparationsIBA
12/2022 - 04/2007
15Proteins (Proteins, Gene)FDA Link
10/2019 - 12/2004
15NF-kappa B (NF-kB)IBA
12/2014 - 09/2007
12Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
12/2014 - 03/2006
12DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
05/2010 - 02/2005
11Neuroprotective AgentsIBA
01/2018 - 04/2007
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2010 - 03/2006
10EnzymesIBA
07/2020 - 02/2005
9moringinIBA
05/2021 - 01/2016
9Biological ProductsIBA
07/2020 - 06/2010
9thioglucosidaseIBA
02/2017 - 08/2013
8Biomarkers (Surrogate Marker)IBA
01/2021 - 06/2012
8CannabidiolIBA
06/2020 - 04/2015
8Peroxisome Proliferator-Activated Receptors (PPAR)IBA
09/2016 - 07/2008
7Transcription Factors (Transcription Factor)IBA
11/2021 - 01/2008
7Mitogen-Activated Protein KinasesIBA
10/2021 - 04/2008
7MelatoninIBA
05/2020 - 04/2005
7CannabinoidsIBA
11/2019 - 11/2014
7Anticonvulsants (Antiepileptic Drugs)IBA
01/2016 - 12/2010
7ZymosanIBA
07/2011 - 02/2008
7LigandsIBA
02/2010 - 07/2005
7Uridine Triphosphate (UTP)IBA
02/2010 - 02/2005
6nabiximols (Sativex)IBA
08/2020 - 01/2015
6isothiocyanic acidIBA
07/2017 - 01/2015
6GlucocorticoidsIBA
02/2017 - 06/2008
6CarrageenanIBA
10/2011 - 04/2009
6Poly Adenosine Diphosphate RiboseIBA
07/2011 - 06/2006
5MicroRNAs (MicroRNA)IBA
10/2021 - 08/2019
5AntioxidantsIBA
03/2021 - 01/2015
5Caspase 3 (Caspase-3)IBA
01/2021 - 12/2014
5Dopamine (Intropin)FDA LinkGeneric
07/2020 - 01/2015
5Macrophage Migration-Inhibitory FactorsIBA
03/2020 - 04/2018
5Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2018 - 02/2006
5CateninsIBA
01/2018 - 01/2016
5LipopolysaccharidesIBA
08/2017 - 01/2008
5BaclofenFDA LinkGeneric
12/2014 - 04/2007
5InterferonsIBA
09/2014 - 01/2006
5Peroxynitrous Acid (Peroxynitrite)IBA
11/2010 - 04/2005
5Fas Ligand Protein (Fas Ligand)IBA
09/2010 - 09/2007
4Reactive Oxygen Species (Oxygen Radicals)IBA
06/2021 - 06/2006
4Antidepressive Agents (Antidepressants)IBA
10/2020 - 05/2010
4tau Proteins (tau Protein)IBA
01/2020 - 12/2010
4Amyloid (Amyloid Fibrils)IBA
01/2020 - 01/2014
4IsothiocyanatesIBA
03/2018 - 10/2015

Therapy/Procedure

53Therapeutics
03/2022 - 01/2005
31Laminectomy
01/2015 - 02/2005
16Cognitive Training
02/2021 - 07/2014
8Neurological Rehabilitation
08/2021 - 01/2015
8Transcranial Magnetic Stimulation
02/2021 - 01/2004
5Drug Therapy (Chemotherapy)
12/2022 - 11/2013
4Activities of Daily Living (ADL)
05/2019 - 03/2017
4Transcranial Direct Current Stimulation
08/2018 - 01/2015